test

[PRESSWIRE] SECAUCUS, N.J., April 21, 2020 -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples. With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as well as molecular diagnostic laboratory testing.  

[PRESSWIRE] ALBANY, New York, June 9, 2020 -- Video telemedicine has become an integral part of remote health care services, gaining popularity due to their use in chronic disease management, driving the evolution of the video telemedicine market. In the light of emerging coronavirus disease (COVID-19) pandemic and subsequent social distancing restrictions, video telemedicine services have become a necessity for a substantial portion of patient populations, especially in disease diagnosis.

1

[PRESSWIRE] Vienna - 4 June, 2020 -- The Austrian biotech company CEBINA GmbH announces that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale efforts offering short-, mid- and longer-term solutions to fight the COVID-19 pandemic. This seed funding will support proof-of-concept studies of the vaccine that will allow progress to pre-clinical development, scheduled for Q1/2021. The funds are provided by the Blom Family Office.

1

[PRESSWIRE] Luxembourg - 14 May, 2020 -- The pandemic has taken the medical world by surprise and challenged the medical device industry, putting a heavy strain on manufacturers. How does a CEO juggle between the intensifying demand for reliable medical equipment, the need for innovations, and the safety of his employees to make sure that COVID-19 is behind us in the shortest time possible?

1

[PRESSWIRE] Austria - 20 April, 2020 -- Austrian biotech company Calyxha Biotechnologies GmbH is pleased to announce the grant of European Patent No. EP3383381. This patent covers the use of calixarene compounds for neurodegenerative diseases, including Parkinson’s disease. It represents the company’s first granted patent, with prosecution of the corresponding patent applications ongoing in other territories.

1

[PRESSWIRE] Parma, Italy - April 9, 2020 -- The ERA-EDTA has established a European database that collects granular data of individual dialysis patients and transplanted patients with COVID-19. The hope is to achieve insights into patient and treatment characteristics that are related to outcome and to learn about modifiable risk factors, which would help to improve prognoses.

1

[PRESSWIRE] Reykjavik, Iceland - 26 March 2020 -- The first Coronavirus Medical Express flight departs Shanghai at 23:30 GMT today airlifting urgently needed supplies to fight the coronavirus from China to Europe.

[PRESSWIRE] 19.03.20 - Chicago, IL. - Surgisphere ha sviluppato uno strumento per il triage del COVID-19 che aiuta a gestire le priorità nelle cure per i pazienti in urgente stato di necessità.

1

[PRESSWIRE] Chicago, IL United States - 19 March, 2020 -- Surgisphere has developed a COVID-19 triage tool that helps prioritize care for patients who are in urgent need of care.

[PRESSWIRE] Parma, Italy - March 12, 2020 -- Kidney involvement seems to be frequent in patients who have tested positive for coronavirus. Acute kidney injury might be a predictor of mortality in infected patients.